港股異動 | 鐵貨(1029.HK)續漲10.6% 鐵礦石期貨主力合約大漲
格隆匯12月11日丨鐵貨(1029.HK)股價高位震盪,最高見0.183港元續創2019年7月份以來新高,現報0.177港元,漲幅10.63%,最新總市值12.56億港元,月內累計漲逾65%。鐵礦石期貨主力合約今日早間突破1000元/噸,最高見1042元/噸,現報994元元/噸,漲幅4.8%。國信證券指,展望2021年,行業供給增量有限,四大礦山主要增產來源為淡水河谷停產礦山復產,但復產進度存在較大的不確定性;而需求有望保持增長,隨着疫苗研發的進展以及各國經濟扶持政策的推動,全球鋼鐵企業有望陸續復產,帶動鐵礦石消費增長。鐵礦石供需仍將保持緊平衡狀態,促使礦價保持高位。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.